Advertisement

Drugs & Therapy Perspectives

, Volume 4, Issue 6, pp 14–16 | Cite as

QOL assessment is clinically relevant in patients with rheumatoid arthritis

Drug Economics and Quality of Life
  • 4 Downloads

Keywords

Rheumatoid Arthritis Auranofin Nizatidine British National Formulary Arthritis Impact Measurement Scale 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bell MJ, et al. Arth Rheum 33: 591–601, 1990CrossRefGoogle Scholar
  2. 2.
    Bendtsen P, et al. PharmacoEconomics 5: 286–298, 1994PubMedCrossRefGoogle Scholar
  3. 3.
    Bendtsen P, Hörnquist JO. Qual Life Res 1: 297–305, 1992CrossRefGoogle Scholar
  4. 4.
    Jaeschke R, et al. PharmacoEconomics 1: 84–94, 1992PubMedCrossRefGoogle Scholar
  5. 5.
    Bendtsen P, Hörnquist JO. Clin Exp Rheumatol 11: 495–502, 1993PubMedGoogle Scholar
  6. 6.
    Makisara GL, Makisara P. Clin Rheumatol 1: 117–125, 1982PubMedCrossRefGoogle Scholar
  7. 7.
    Wolfe F. J Rheumatol 17 (Suppl. 22): 24–32, 1990Google Scholar
  8. 8.
    Borstlap M, et al. Clin Rheum 13: 45–50, 1994CrossRefGoogle Scholar
  9. 9.
    Tugwell P, et al. Arch Intern Med 150: 59–62, 1990PubMedCrossRefGoogle Scholar
  10. 10.
    Borg G, et al. J Rheumatol 18: 1015–1020, 1991PubMedGoogle Scholar
  11. 11.
    Bombardier C, et al. Am J Med 81: 565–578, 1986PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1994

Personalised recommendations